State Street’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.15M Sell
849,424
-51,930
-6% -$498K ﹤0.01% 2708
2025
Q1
$5.65M Sell
901,354
-138,582
-13% -$869K ﹤0.01% 2827
2024
Q4
$8.44M Buy
1,039,936
+117,148
+13% +$951K ﹤0.01% 2720
2024
Q3
$16.7M Buy
922,788
+137,539
+18% +$2.49M ﹤0.01% 2320
2024
Q2
$8.09M Buy
785,249
+68,048
+9% +$701K ﹤0.01% 2688
2024
Q1
$7.62M Buy
717,201
+29,364
+4% +$312K ﹤0.01% 2734
2023
Q4
$6.28M Buy
687,837
+20,241
+3% +$185K ﹤0.01% 2847
2023
Q3
$6.92M Buy
667,596
+137,753
+26% +$1.43M ﹤0.01% 2766
2023
Q2
$7.59M Buy
529,843
+66,100
+14% +$947K ﹤0.01% 2792
2023
Q1
$3.31M Buy
463,743
+12,394
+3% +$88.5K ﹤0.01% 3144
2022
Q4
$5.06M Buy
451,349
+5,854
+1% +$65.7K ﹤0.01% 3038
2022
Q3
$4.94M Buy
445,495
+36,613
+9% +$406K ﹤0.01% 3067
2022
Q2
$3.45M Buy
408,882
+43,838
+12% +$370K ﹤0.01% 3278
2022
Q1
$4.97M Buy
365,044
+23,104
+7% +$314K ﹤0.01% 3183
2021
Q4
$6.73M Sell
341,940
-12,824
-4% -$252K ﹤0.01% 3109
2021
Q3
$11.4M Buy
354,764
+14,461
+4% +$464K ﹤0.01% 2811
2021
Q2
$11.5M Buy
340,303
+123,105
+57% +$4.17M ﹤0.01% 2831
2021
Q1
$8.16M Buy
217,198
+8,148
+4% +$306K ﹤0.01% 2834
2020
Q4
$6.95M Sell
209,050
-5,257
-2% -$175K ﹤0.01% 2805
2020
Q3
$7.86M Buy
214,307
+1,500
+0.7% +$55K ﹤0.01% 2568
2020
Q2
$7M Buy
212,807
+25,499
+14% +$839K ﹤0.01% 2597
2020
Q1
$4.84M Buy
187,308
+62,065
+50% +$1.6M ﹤0.01% 2644
2019
Q4
$3.9M Buy
+125,243
New +$3.9M ﹤0.01% 2957